Colon Targeting pH‐Responsive Coacervate Microdroplets for Treatment of Ulcerative Colitis
Small · 2024-08 · 20 (33)
DOI: 10.1002/smll.202311890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 05.04.2024. Verfasst von Yinmei Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colon. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: HUST Academic Frontier Youth Team, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Ulcerative colitis (UC), an immune‐mediated chronic inflammatory disease, drastically impacts patients' quality of life and increases their risk of colorectal cancer worldwide. However, effective oral targeted delivery and retention of drugs in colonic lesions are still great challenges in the treatment of UC. Coacervate microdroplets, formed by liquid–liquid phase separation, are recently explored in drug delivery as the simplicity in fabrication, spontaneous enrichment on small molecules and biological macromolecules, and high drug loading capacity. Herein, in this study, a biocompatible diethylaminoethyl‐dextran hydrochloride/sodium polyphenylene sulfonate coacervates, coated with eudragit S100 to improve the stability and colon targeting ability, named EU‐Coac, is developed. Emodin, an active ingredient in traditional Chinese herbs proven to alleviate UC symptoms, is loaded in EU‐Coac (EMO@EU‐Coac) showing good stability in gastric acid and pepsin and pH‐responsive release behavior. After oral administration, EMO@EU‐Coac can effectively target and retain in the colon, displaying good therapeutic effects on UC treatment through attenuating inflammation and oxidative stress response, repairing colonic epithelia, as well as regulating intestinal flora balance. In short, this study provides a novel and facile coacervate microdroplet delivery system for UC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China.
- Hubei Engineering Research Centre for Novel Drug Delivery System, Wuhan, 430030, China.
- National Engineering Research Center for Nanomedicine, Huazhong University of Science and Technology, Wuhan, 430030, China.
ORCID-Profile: Boning Niu, Zhiping Zhang
Förderung
- HUST Academic Frontier Youth Team
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Wuhan Science and Technology Plan
- Fujian Provincial Key Laboratory of Innovative Drug Target Research
Zitieren
APA
Tian, Y., Hu, Q., Sun, Z., Yu, Y., Li, X., Tian, T., Bi, X., Li, Y., Niu, B., & Zhang, Z. (2024). Colon Targeting pH‐Responsive Coacervate Microdroplets for Treatment of Ulcerative Colitis. Small, 20(33). https://doi.org/10.1002/smll.202311890
Vancouver
Tian Y, Hu Q, Sun Z, Yu Y, Li X, Tian T, et al. Colon Targeting pH‐Responsive Coacervate Microdroplets for Treatment of Ulcerative Colitis. Small. 2024;20(33). doi:10.1002/smll.202311890
BibTeX
@article{Tian2024,
author = {Tian, Yinmei and Hu, Qian and Sun, Zhengjun and Yu, Yulin and Li, Xiaonan and Tian, Tianyi and Bi, Xinying and Li, Yang and Niu, Boning and Zhang, Zhiping},
title = {Colon Targeting pH‐Responsive Coacervate Microdroplets for Treatment of Ulcerative Colitis},
journal = {Small},
year = {2024},
volume = {20},
number = {33},
doi = {10.1002/smll.202311890}
}
EUVIMED